shelter
medicine
Canine Influenza Virus: Fact or Fiction?
An expert breaks down what you need to know

The H1N1 virus has been making headlines
for nearly a year, yet there is still much confusion about the reality of the situation. Reports
that use words like “outbreak” and “emerging
disease” often incite fear and leave us gripped
by overly active imaginations. Picturing imminent world collapse, we forget to take the
time to study available information, separate
fact from fiction, and follow a reasonable
course of action.
In the veterinary and sheltering worlds,
there are parallels in the reaction to the spread
of canine influenza virus (CIV), which was
first identified and made headlines in 2004.
Recently, CIV has been back in the spotlight following conditional licensure and release of the first canine influenza vaccine.
Many questions—How effective is the vaccine? Should we test our animals? How concerned should we be?—have been circulating
in the animal sheltering community. It seems
an ideal time for those of us concerned about
the health and welfare of dogs to refresh ourselves with available information, determine
a reasonable action plan related to canine influenza virus, and separate fact from fiction.

Fact: When dealing with “kennel
cough” in a shelter dog or a whole
population of dogs, CIV is one of
many possible causes to consider.
Canine infectious respiratory disease complex, or “kennel cough,” is a common syndrome—especially in shelter dogs. Most
humane facilities that house populations of
dogs manage cases of infectious cough on
a daily basis. The primary agents associated
with the kennel cough syndrome include bacterial and viral pathogens, such as Bordetella
bronchiseptica, Mycoplasma species, canine
distemper virus, canine parainfluenza virus,
and canine adenovirus-2. Each of these
agents can cause similar clinical signs, including sudden onset of fever, loss of appetite, cough, and nasal discharge.
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There is no way to prevent canine influenza virus so far, but it’s possible for shelters to limit
the consequences of widespread disease and contribute to an improved understanding of
how the virus transmits, persists, and can be prevented.

In early 2004, an influenza A virus was
recovered from the lung tissue of a racing
greyhound who had succumbed to severe
respiratory disease in Florida. Analysis of
the viral genome revealed that the isolate
was closely related to an equine H3N8 influenza virus. Since 2004, thousands of CIV
cases and confirmed outbreaks have been
reported in more than 25 states and the
District of Columbia, according to Cornell
Univer sit y’s Animal Health Diagnostic
Center webpage (diaglab.vet.cornell.edu/issues/civ-stat.asp).
The total number of CIV cases that have
occurred is not known. However, a recent
one-year study, conducted by real-time
polymerase chain reaction (PCR) testing at

Colorado State University, found dogs shedding the CIV virus in 11 out of 16 shelters (69
percent) that were experiencing outbreaks of
canine respiratory disease.
CIV is clearly an important new differential diagnosis for any dog with acute respiratory disease.

Fiction: Canine influenza is really
only a problem in animal shelters.
Dogs of any age, breed, and health status are
susceptible to canine influenza if they have
not had previous exposure to the virus. Like
influenza viruses that affect other species,
CIV is easily transmitted in cough and sneeze
droplets and can be transmitted through fomites (hands, clothing, and other objects that
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Laboratory diagnosis is required to
distinguish canine influenza from other
causes of acute respiratory disease. Here, a
veterinarian acquires a nasal swab from a
dog to submit for polymerase chain reaction
(PCR) testing.

This photo was taken in a shelter where a
high rate of canine infectious respiratory
disease was affecting the dog population.
Nearly every dog had been placed on
antimicrobials, which is not a recommended
practice.

can be contaminated with disease agents and
act to spread the disease).
That said, the risk of infection is lowest
for pet dogs who have little exposure to other
dogs or dog facilities, and greatest for dogs
who are housed in group environments or
have frequent contact with other dogs, such
as through boarding kennels, day cares, dog
parks, veterinary hospitals, and shelters.
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CIV does not spontaneously erupt in facilities; initial cases have to enter from community sources to start the cycle of infection,
reflecting a community problem.
The virus does not survive long in the environment (it can remain viable on surfaces
for 48 hours, on clothing for 24 hours, and on
hands for 12 hours) and is easily killed with
routine cleaning and disinfection, but many
facilities do struggle to break the cycle of
transmission once the virus is introduced.
There is still much that remains to be studied about how this virus circulates, persists,
and evolves in the dog population—both in
owned and in homeless animals.

Fiction: Dogs with CIV frequently
die rapidly, with signs of
hemorrhagic pneumonia.
Initial reports indicated that canine influenza
virus caused significant mortality in affected
dogs. But it now appears that the disease behaves like influenza infections in many other
species. Most dogs will recover without serious complications.
Following infection, the virus replicates
quickly in dogs’ respiratory tract cells. There is
a two-to-five-day period during which nonspecific clinical signs (such as fever and lethargy)
occur. It is during this early incubation period
that peak nasal viral shedding occurs. Around
days five to seven, more visible clinical signs of
cough and nasal discharge develop. Typically,
viral shedding wanes by days seven to 10, but
that can vary in individual dogs.
It is important to note that by the time obvious clinical signs develop, the period when
animals are most infectious often has already
passed. In many facilities where animals are
isolated only after clinical signs are noticed,
infection control becomes a significant challenge because viral shedding and transmission to other dogs has already occurred. The
majority of affected dogs (80-90 percent) will
show mild to no clinical signs, while a smaller
percentage of dogs (10-20 percent) may develop more severe illness characterized by
high fever, lethargy, rapid breathing, and secondary bacterial bronchopneumonia.
In uncomplicated cases, the respiratory
tract may begin to heal in as little as three to
five days following infection. In other cases,
cell damage may predispose animals to acquiring secondary bacterial infections, and
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recovery may take several weeks. Rarely,
severe to fatal disease may occur. Thus CIV
is a disease that causes a high morbidity
(many affected), but a relatively low mortality
(death rate) when appropriately diagnosed
and managed.

Fiction: Outbreaks of CIV are easily
recognized in a facility or population
of dogs.
Much focus has been placed on outbreak
recognition and management. When CIV first
enters a group of susceptible dogs, a presumptive diagnosis may be made based on the
rapid spread of an acute respiratory disease
accompanied by fever that is unrelated to vaccine history and associated with a prolonged
or complete lack of response to therapies that
are generally effective for other causes of canine infectious respiratory disease.
Laboratory diagnosis is still required to
differentiate CIV from other causes of acute
respiratory disease, but the rapid spread can
be suggestive. However, when CIV enters facilities where kennel cough is already occurring, it may not be immediately recognized as
anything “new,” but instead may appear to be
a gradual worsening of the existing problem.
In these situations, failure to perform rapid
and appropriate diagnostic testing—and to
offer timely treatment specifically designed
to treat the disease—can lead to decline in
the welfare and health of the entire population. Therefore, in a population of dogs
showing an increase in the number of acute
respiratory disease cases, overall severity of
illness, or a prolonged to complete lack of
response to usually effective therapies, CIV
should be a consideration, and diagnostics
should be pursued.

Fiction: CIV can be diagnosed
based on clinical signs alone.
Laboratory diagnosis is required to distinguish canine influenza from other causes of
acute respiratory disease. There are multiple
diagnostic methods available for testing; each
has strengths and weaknesses.
“Too often, facilities test only one or two
dogs using only one test method, and the diagnosis is missed,” says Gabriele Landolt, a
virologist who is researching canine influenza
in animal shelters through a Morris Animal
Foundation grant. “To identify the causative
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agent accurately and rapidly, thus allowing
to institute optimal control measures, it may
be necessary to combine several diagnostic
tests and test multiple dogs in varying stages
of disease.”
The timing of sample collection relative to
when an animal was infected relates directly
to test performance. Some tests, like PCR
analysis and other methods aimed at detecting the virus, are designed to work during the
first few days following infection, when dogs
are shedding infectious virus but showing few
clinical signs. These tests are preferred for an
early clinical infection.
Other tests, like serology (blood tests),
measure exposure to the virus through antibody levels, which do not develop until at
least seven days following infection (or potentially, following vaccination). A comparison of serum samples taken two weeks apart
is recommended to document recent exposure through a fourfold increase in the levels
of antibodies.
In a population of dogs, the odds of capturing a positive sample increase by collecting samples from multiple animals (five to 10

dogs are recommended) who have entered
the facility at various times and are exhibiting different clinical signs. For more information on testing methods, read the chapter
on canine influenza in the newly available
textbook, Infectious Disease Management in
Animal Shelters.

Fiction: Doxycycline is a
good standard antibiotic
for all dogs with CIV.
Not all dogs affected by CIV will require therapeutic intervention. When medication does
become necessary, there is no single correct
treatment. For many CIV cases, supportive
care may be all that is required. Good nutrition, maintenance of hydration, and minimization of stress are still critical components of
therapy even when medication is in use.
Dogs who show signs of secondary bacterial infections (e.g. mucoid nasal discharge,
productive cough, or pneumonia) should
be treated with broad-spectrum antibiotics.
Ideally, antibiotics should be chosen on the
basis of culture and sensitivity. Until culture
and sensitivity results become available,

broad-spectrum therapy is recommended to
cover most of the likely secondary pathogens.
Cough suppressants are not recommended for CIV dogs experiencing productive
coughs. Some practitioners report anecdotal
response to a single anti-inflammatory dose
of glucocorticoids, but this is not documented
well and not without risk.
Antiviral medications specifically aimed
at influenza infections are available, but not
advocated for use with CIV for several reasons. These drugs must be given very early
in the infection for effect, there are no recommended dosing strategies, there are no
efficacy or safety studies available in dogs,
and the virus may develop resistance to these
drugs. Furthermore, they are expensive medications that—especially these days—are
often being conserved for use in humans.
In severe cases of secondary pneumonia,
oxygen therapy, nebulization, and bronchodilator therapy may be helpful. However, such intensive therapy can be difficult to provide on a
large scale, and if dogs are severely affected and
intensive care is not available, euthanasia may
become necessary for herd welfare reasons.
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Fact: A facility can break the
cycle of transmission.
Ultimately, widespread or uncontrolled respiratory disease can affect an entire community. When CIV is confirmed in a facility,
management decisions must be made to limit
its impact, but CIV is difficult to control in
most populations of dogs for several reasons.
The virus spreads rapidly through the dog
population, in part through sneeze droplets
that can be difficult to contain. While some
infectious dogs may show obvious clinical
signs, others are asymptomatic, yet shedding
infectious agent.
Because of the ease of transmission, an
entire facility—not just the animals with clinical signs—is considered exposed at the time
of diagnosis. Ideally, dogs with clinical signs
should be isolated away from exposed dogs,
who are placed in a CIV quarantine area to
watch for development of symptoms—but this
is not always practical with a CIV quarantine.
In order to break the cycle of infection,
the exposed dog population needs to be contained (no new dogs in and no dogs out) for
the duration of viral shedding. A 14-day quarantine is recommended. Many dogs will remain symptomatic well beyond the time they
are no longer shedding virus.
Shelters and other facilities can achieve
a quarantine in several ways. The simplest
way to end a CIV outbreak is to stop admitting any new dogs for a two-week period.
However, this may not be a possibility for all
facilities, and where it isn’t, new dogs can
be separated from exposed dogs by using a
temporary offsite facility (for either population) for two weeks. In small programs, foster
homes and rescue groups can be used during
the period.
Finally, some shelters have successfully
continued to admit new dogs by strictly separating new intakes from the exposed dogs.
This may mean that the exposed dogs must
be moved and/or grouped in a physical area
of the building distant from where new dogs
enter. Ideally, the two areas should have separate ventilation systems, but at minimum there
should be physical barriers (such as closed
doors) to lessen aerosol transmission.
As with any infectious disease, biosecurity
measures are important. Suggestions include
designating specific staff to care for the un-
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exposed dogs, but if this is not possible, staff
should care for the unexposed dogs first.
Measures that reduce fomite transmission
should be in place, including frequent hand
washing, use of personal protective equipment like disposable gloves, cover-up gowns
and boots, and protocols that encourage following “all-in, all-out” procedures (meaning
that a staffer should enter with all necessary
supplies, perform their tasks in the area, and
then exit, rather than going back and forth
into the area and increasing the chances of
contamination).
Though its effectiveness is controversial,
the use of regularly changed footbaths or disinfectant mats outside of quarantined areas
is unlikely to do harm and may serve as a reminder to staff of other necessary biosecurity
measures.

Fiction: The H3N8 Vaccine is
considered a core shelter vaccine.
When weighing whether the new H3N8 CIV
vaccine will benefit shelters, there are a number of things to consider.
Vaccines are an important part of influenza control in all species, and the development and conditional approval of a vaccine
for canine influenza is an important step toward better management of canine influenza
virus. But before shelters put a new product
into widespread use, they should consider
information about the product, how it works,
and the potential risks and benefits.
It is also important to recognize that
whenever a new vaccine is conditionally released, there are often many factors yet to be
researched. “Some of the currently unknown
aspects of the H3N8 vaccine include the maximum duration of immunity induced by the
vaccine, whether there is benefit in vaccinating around the time of exposure, and whether
evolution of field strains of the canine influenza virus might make the vaccine ineffective
over time,” says Melissa Kennedy, a clinical virologist at the University of Tennessee College
of Veterinary Medicine.
Shelters also must consider that the vaccine is an inactivated product. It is labeled
to be given as two doses spread two to three
weeks apart to healthy dogs 6 weeks or older.
This means that it can take weeks for a dog
to respond maximally to the vaccine, and so
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shelters that house dogs long term may benefit more than those with short turnover times.
The only available efficacy studies by the
vaccine company demonstrate that use of the
product lessens clinical signs of disease and
decreases—but does not eliminate—virus
shedding. Influenza vaccines used in many
species have similar effects; vaccinated dogs
can still become infected and shed virus, but
may not become as clinically affected and
may not infect other dogs as readily. This vaccine has been termed a “lifestyle vaccine,”
much like available vaccines for Bordetella
bronchiseptica. The best use of the vaccine
appears to be for preemptive vaccination of
dogs at high risk of exposure to CIV.

The Last Word
Much like the present situation with H1N1,
canine influenza virus—although a serious
issue for shelters—is certainly not grounds
for panic. The recent identification of H1N1
in a cat, and apparent transmission of H1N1
from humans to other animals, serves as a
reminder that influenza viruses are notoriously unpredictable and require vigilant
monitoring.
Cats do not appear to present a significant
risk for viral transmission of H1N1, and the canine influenza H3N8 virus seems to transmit
primarily dog-to-dog with minimal zoonotic
risk, but much remains unknown about both
of these viruses. Thus far, there is no way to
prevent CIV, but it is possible for shelters to
limit the consequences of widespread disease
and contribute to an improved understanding
of how the virus transmits, persists, and can
be prevented through standard infection-control measures, diagnostic testing, separation
of affected animals, appropriate therapy, and
proactive community education.
Miranda Spindel is the director of veterinary
outreach at the ASPCA and past president of
the Association of Shelter Veterinarians. She
initiated and completed the first residency in
shelter medicine offered though Colorado
State Unive r sit y and founde d the C SU
student chapter of the Association of Shelter
Veterinarians.

